AI News AI资讯 2h ago Updated 1h ago 更新于 1小时前 36

A-share three major indices collectively open lower, Weite falls over 9% A股三大指数集体低开,唯特偶跌超9%

At 9:30 this morning, the opening gong of China’s A-share market sounded, but instead of a victory fanfare, it brought a muffled hum of low pressure. The Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index all opened lower without exception. This opening act set a somewhat somber tone for June’s market. However, what’s more noteworthy than the overall index decline is that glaring splash of red on the trading board—among the red and green sectors symbolizing rises and falls, Vi 今天早上九点半,A股开盘的锣声敲响,但传来的不是凯歌,而是一片低气压的闷响。沪指、深成指、创业板指无一幸免,集体低开。这个开场白,给六月的市场定下了一个略显沉闷的基调。但比指数整体下滑更值得关注的,是盘面中那抹刺眼的红色——在象征上涨的红绿阵营里,唯特偶那接近跌停的9%跌幅,像一记闷棍,敲在了半导体板块本就脆弱的信心上。

60
Hot 热度
60
Quality 质量
30
Impact 影响力

Analysis 深度分析

This isn’t just a "Black Friday" for Vitech alone. Longsys fell over 5%, dragging Jinhua Energy from the coal sector down more than 2% as well. Semiconductors, computer hardware, and coal—these "hardcore" sectors collectively slump at the top of the decliners’ list. This scene is telling. Not long ago, the grand narrative of AI-driven computing power demand and domestic substitution had these sectors cradled in the palms of investors. Now? The tide has receded rather quickly. Capital, like a pack of keen-scented scavengers, has begun a panicked retreat from previously crowded, overvalued tracks, even those wearing the trendiest labels. Mr. Market’s patience is clearly far shorter than the pace of technological iteration.

Interestingly, the capital that fled didn’t disappear; it quickly found footing at the other end of the trading board. Energy equipment, biotech, and pharmaceuticals rose against the trend. Shuangta Pharma and Menovo surged over 4%, while Jereh Group climbed over 3%. This extreme differentiation of "sunshine in the east while rain falls in the west" reveals a cold truth: today’s market offers no honeymoon period of broad-based gains, only naked sector rotation and capital games. As capital abandons "stories," it turns toward sectors with more defensive value or short-term, certainty-driven catalysts (such as pharmaceutical pipeline progress or energy equipment order expectations). It resembles a capital market "battle royale," where the survivors aren’t the strongest but those best adapted to the current changing environment.

Shifting focus from the ever-fluctuating K-line to the central bank’s operations might offer further insight. Today, the People’s Bank of China conducted a 7-day reverse repo operation of 215 billion yuan, with the interest rate steady at 1.40%. On the surface, this net injection of 92 billion yuan seems to add a touch of warmth to the market. But don’t over-interpret it. This "increased volume, unchanged price" operation is more akin to an IV drip for market sentiment—preventing unnecessary panic from a sudden liquidity squeeze rather than a stimulant-style full-scale stimulus. The central bank is carefully maintaining a balance: ensuring the financial system isn’t starved of liquidity while avoiding any illusion of "flood-like" stimulus. This precise, drip-style liquidity management itself reveals the current leadership’s clear awareness and cautious stance on the "lukewarm water" state of the economy and market. They don’t want to push it forward, but they absolutely won’t allow it to fall.

Returning to the market itself, today’s lower opening and divergence may be a concentrated release of pent-up emotion. Previously, everything shrouded in the AI halo was chased indiscriminately, with valuations long detached from fundamentals. Now, the market is using a microscope to scrutinize these companies’ actual performance, order visibility, and valuation rationality. Those "pseudo-growth stocks" lacking solid business support and relying purely on concept hype naturally bear the brunt. In contrast, companies with genuine technological moats and deliverable performance may actually reveal their value after the sediment settles.

Therefore, today’s trading session is less a decline and more a brutal bubble squeeze and value reassessment. It mercilessly declares: the era of making money by blindly buying into grand narratives is彻底 over. What follows will be a "deep-water zone" that tests professional judgment and stock-picking ability. Investors need to shift from chasing trends back to researching company fundamentals and industry logic. This is painful, but for the market’s long-term health, it’s a necessary process of scraping away decay to heal. For those still shaken by Vitech-style plunges today, perhaps they should ask themselves: Was the initial reason for buying based on sound business logic, or merely the anxiety of fearing to miss a feast? The answer often determines whether you’ll be standing or lying down in the next round of market differentiation.

今天早上九点半,A股开盘的锣声敲响,但传来的不是凯歌,而是一片低气压的闷响。沪指、深成指、创业板指无一幸免,集体低开。这个开场白,给六月的市场定下了一个略显沉闷的基调。但比指数整体下滑更值得关注的,是盘面中那抹刺眼的红色——在象征上涨的红绿阵营里,唯特偶那接近跌停的9%跌幅,像一记闷棍,敲在了半导体板块本就脆弱的信心上。

这不仅仅是唯特偶一家公司的“黑色星期五”。江波龙跌超5%,连带着煤炭板块的晋控煤业也下滑超2%,半导体、电脑硬件和煤炭这些“硬核”板块集体趴在跌幅榜前列。这景象耐人寻味。就在不久前,AI驱动的算力需求、国产替代的宏大叙事还把这些板块捧在手心。现在呢?潮水退得有点快。资金像一群嗅觉灵敏的食腐动物,开始从前期拥挤、估值虚高的赛道里仓皇撤出,哪怕这些赛道贴着最时髦的标签。市场先生的耐心,显然比技术迭代的速度要短得多。

有意思的是,资金撤离后并没有消失,它们迅速在盘面的另一端找到了落脚点。能源设备、生物科技、制药这些板块逆势领涨。舒泰神、美诺华涨超4%,杰瑞股份也涨超3%。这种“东边日出西边雨”的极致分化,揭示了一个冰冷的真相:当下的市场没有普涨的蜜月期,只有赤裸裸的板块轮动和资金博弈。资金在抛弃“故事”的同时,转向了更具防御性、或有着短期确定性催化(比如医药的管线进展、能源设备的订单预期)的领域。这像极了一场资本市场的“大逃杀”,活下来的不是最强壮的,而是最能适应当前环境变化的。

把目光从瞬息万变的K线移开,看一眼央行的操作,或许能读懂更多。今日央行开展2150亿元7天期逆回购操作,利率稳在1.40%。单看这920亿元的净投放量,似乎是向市场注入了些许暖意。但请别过度解读。这种“量增价平”的操作,更像是在为市场情绪“打点滴”,防止流动性突然收紧引发不必要的恐慌,而非强心针式的全面刺激。央行在小心翼翼地维持着一种平衡:既要保证金融体系不缺水,又绝不能给人以“大水漫灌”的错觉。这精准的、滴灌式的流动性管理,本身就说明了当前决策层对经济和市场“温吞水”状态的心知肚明和审慎态度。他们不想推,但也绝不允许掉。

回到市场本身,今天的低开和分化,或许是一次积压情绪的集中释放。此前被AI光环笼罩的一切都被无脑追捧,估值早已脱离基本面。现在,市场开始用显微镜审视这些公司的实际业绩、订单能见度和估值合理性。那些缺乏扎实业务支撑、纯靠概念炒作的“伪成长股”,自然首当其冲。而真正有技术护城河、业绩能兑现的公司,反倒可能在泥沙俱下后显现出价值。

所以,今天的盘面与其说是下跌,不如说是一次残酷的挤泡沫和价值重估。它无情地宣告:靠宏大叙事闭眼买入就能赚钱的阶段,已经彻底过去。接下来,将是更考验专业判断和个股挖掘能力的“深水区”。投资者需要从追逐风口,回归到研究公司质地和产业逻辑上来。这很痛苦,但对市场的长期健康而言,却是必经的刮骨疗毒。对于那些今天还在为唯特偶式暴跌心惊肉跳的投资者,或许该问问自己:当初买入的理由,是经得起推敲的商业逻辑,还是仅仅因为怕错过一场盛宴的焦虑?答案,往往决定了下一轮市场分化时,你是站着还是躺着。

Disclaimer: The above content is generated by AI and is for reference only. 免责声明:以上内容由 AI 生成,仅供参考。

金融AI 金融AI
Share: 分享到: